<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study</dc:title>
  <dc:creator>Segeral, O.</dc:creator>
  <dc:creator>N'Diaye, D. S.</dc:creator>
  <dc:creator>Prak, S.</dc:creator>
  <dc:creator>Nouhin, J.</dc:creator>
  <dc:creator>Chhun, S.</dc:creator>
  <dc:creator>Khamduang, W.</dc:creator>
  <dc:creator>Chim, K.</dc:creator>
  <dc:creator>Roque-Afonso, A. M.</dc:creator>
  <dc:creator>Piola, P.</dc:creator>
  <dc:creator>Borand, L.</dc:creator>
  <dc:creator>/Ngo-Giang-Huong, Nicole</dc:creator>
  <dc:creator>Rouet, F.</dc:creator>
  <dc:creator>ANRS Study Group</dc:creator>
  <dc:subject>Cambodia</dc:subject>
  <dc:subject>Hepatitis B virus</dc:subject>
  <dc:subject>Rapid diagnostic tests</dc:subject>
  <dc:subject>Pregnant women</dc:subject>
  <dc:subject>Mother-to-child transmission</dc:subject>
  <dc:description>Background: In Cambodia, access to hepatitis B surface antigen (HBsAg) screening is low for pregnant women and Hepatitis B Virus (HBV) DNA quantification is poorly accessible. Objectives: To evaluate the performance of a serial algorithm using two HBV rapid diagnostic tests (RDTs), in which samples positive for HBsAg were further tested for HBeAg as a surrogate marker for HBV DNA quantification. Study design: In 2015, we prospectively collected plasma samples from 250 pregnant women consulting for antenatal care in one hospital in Phnom Penh including 128 with a known positive HBsAg status. All specimens were tested with the SD BIOLINE HBsAg RDT and HBsAg ELISA assay. In ELISA-positive samples, HBeAg status was determined using the SD BIOLINE HBeAg RDT and HBV DNA quantification was assessed. Results: Sensitivity and specificity of HBsAg RDT were 99.2% (97.7-99.9) and 100% (97.0-100), respectively. Among the 128 ELISA-positive samples, 29 (23%) tested HBeAg positive and 34 (26.5%) had HBV DNA &gt; 5.3 Log(10) IU/mL. Sensitivity and specificity of HBeAg RDT in identifying viremic samples were 76.5% (62.2.0-90.7) and 96.8% (93.3-100) for HBV DNA &gt; 5.3 Log(10) IU/mL and 89.3% (77.8-100) and 96.0% (92.2-99.8) for HBV DNA &gt; 7.3 Log(10) IU/mL. Among the 99 negative HBeAg RDT women, 8 had HBV DNA &gt; 5.3 Log10 IU/mL and 7 of them harbored BCP/PC HBV mutants. Conclusions: A combination of HBsAg and HBeAg RDTs could be a low-cost strategy to identify HBV-infected pregnant women at risk of perinatal transmission in a country were HBV DNA quantification is not routinely available.</dc:description>
  <dc:date>2018</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010074825</dc:identifier>
  <dc:identifier>fdi:010074825</dc:identifier>
  <dc:identifier>Segeral O., N'Diaye D. S., Prak S., Nouhin J., Chhun S., Khamduang W., Chim K., Roque-Afonso A. M., Piola P., Borand L., Ngo-Giang-Huong Nicole, Rouet F., ANRS Study Group. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study. 2018, 109,  29-34</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>CAMBODGE</dc:coverage>
</oai_dc:dc>
